To amend the Public Health Service Act to provide for Centers for Clinical Discovery through grants from the Director of the Agency for Healthcare Research and Quality.

H.R. 3168 would establish a grant program to create "Centers for Clinical Discovery" aimed at accelerating the development of new medical treatments and diagnostic tools. These centers would bring together specialized researchers, advanced technology, and patients to focus on "personalized medicine," which tailors healthcare to an individual’s specific genetic makeup and molecular biology. For citizens, this legislation seeks to move medical research away from a one-size-fits-all approach toward more precise therapies designed to be more effective for a person's unique physiology.